Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Exploring new opportunities within the fast-growing market of microfluidics
This facility marks a significant milestone in transforming the global food industr
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
New research labs and process development services to enable next generation therapeutics
Subscribe To Our Newsletter & Stay Updated
